ABSTRACT
A high-performance liquid chromatogaphic method was developed for determining the concentrations of ticarcillin (TIPC) epimers in human plasma and urine. Samples were prepared for HPLC analysis with a solid-phase extraction method and the concentrations of TIPC epimers were determined using reversed-phase HPLC. The mobile phase was a mixture of 0.005 M phosphate buffer (pH 7.0) and methanol (12:1, v/v) with a flow-rate of 1.0 ml/min. TIPC epimers were detected at 254 nm. Baseline separation of the two epimers was observed for both plasma and urine samples with a detection limit of ca. 1 microg/ml with a S/N ratio of 3. No peaks interfering with either of the TIPC epimers were observed on the HPLC chromatograms for blank plasma and urine. The recovery was more than 80% for both plasma and urine samples. C.V. values for intra- and inter-day variabilities were 0.9-2.1 and 1.1-6.4%, respectively, at concentrations ranging between 5 and 200 microg/ml. The present method was used to determine the concentrations of TIPC epimers in plasma and urine following intravenous injection of TIPC to a human volunteer. It was found that both epimers were actively secreted into urine and that the secretion of TIPC was not stereoselective. Plasma protein binding was also measured, which revealed stereoselective binding of TIPC in human plasma.
Subject(s)
Penicillins/blood , Penicillins/urine , Ticarcillin/blood , Ticarcillin/urine , Adult , Blood Proteins/metabolism , Chromatography, High Pressure Liquid , Drug Antagonism , Humans , Male , Penicillins/pharmacokinetics , Probenecid/pharmacology , Protein Binding , Stereoisomerism , Ticarcillin/pharmacokineticsABSTRACT
A liquid chromatographic assay for ticarcillin (ticar.) in plasma and urine is described. For analysis, the internal standard cefoperazone (cfp) is dissolved in acetonitrile, which is used for precipitating the protein. The supernatant is evaporated, reconstituted in running mobile phase and injected directly onto the reversed-phase C18 column, with detection at 205 nm. The mobile phase is composed of water-acetonitrile-o-phosphoric acid-tetramethylammonium chloride (TMA). Coefficients of variation for reproducibility were in the range of 2.2-15.5% for extra-low, low, medium and high controls. Limits of detection were 0.5 microgram ml-1 for plasma and 1 microgram ml-1 for urine. No interference from other cephalosporins or other antibiotics was noted. This liquid chromatographic assay is simple, accurate, requires no extraction and overcomes previous problems related to the drug's peak splitting due to isomerization.
Subject(s)
Ticarcillin/blood , Ticarcillin/urine , Calibration , Chromatography, Liquid/methods , Drug Stability , Humans , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
We compared the pharmacokinetics of ticarcillin at a dose of 120 mg/kg in 11 patients with cystic fibrosis to 11 control subjects matched for age and sex. The mean elimination half-life of ticarcillin in serum was 70.8 minutes in the control subjects and 53.1 minutes in the patients with cystic fibrosis. The total body clearance of ticarcillin was significantly higher in cystic fibrosis patients (65.6 +/- 22.0 versus 46.2 +/- 10.9 ml/min/m2 in control subjects; p = 0.017). The nonrenal clearance of ticarcillin was also significantly higher in patients with cystic fibrosis (24.8 +/- 11.1 versus 13.3 +/- 6.0 ml/min/m2 for the control group; p = 0.006). There was no significant difference in volume of distribution between the two groups. We concluded that the shorter elimination half-life and the higher total body clearance of ticarcillin in patients with cystic fibrosis are a result of an increase in both renal and nonrenal elimination.
Subject(s)
Cystic Fibrosis/metabolism , Penicillins/pharmacokinetics , Ticarcillin/pharmacokinetics , Adolescent , Adult , Chromatography, High Pressure Liquid , Female , Half-Life , Humans , Male , Metabolic Clearance Rate , Prospective Studies , Ticarcillin/blood , Ticarcillin/urineABSTRACT
The amounts of creatinine, protein, carbohydrate and sialic acid in the urine of 19 patients with cystic fibrosis (CF), 12 normal controls and 11 pathological controls with chronic lung disease have been determined. The mean creatinine excretion levels of the total CF group as well as the CF subgroups are significantly decreased when compared to normal controls but comparable to pathological controls. Mean urinary protein levels appear to be increased in patients with CF compared to normal controls and pathological controls but the increased levels resulted from factors (e.g., presence of diabetes mellitus) other than CF. No significant differences were found in amounts of total carbohydrate and sialic acid in urine and fractionated urinary preparations for the total group of nondiabetic patients with CF when compared to both normal and pathological controls. HPLC fractionation of low Mr (less than 10,000 Daltons) urinary preparations indicated the presence of an unknown peak in all of the antibiotic-treated CF patients, 43% of CF patients on low or no medication, 17% of the normal controls and 9% of the pathological controls. The present results illustrate the importance of including appropriate pathological controls and dividing patients with CF into subgroups according to clinical factors and types of therapy employed.
Subject(s)
Cystic Fibrosis/urine , Lung Diseases/urine , Adolescent , Adult , Biological Assay , Carbohydrates/urine , Chemical Fractionation , Child , Chromatography, High Pressure Liquid , Chronic Disease , Creatinine/urine , Female , Humans , Hydrogen-Ion Concentration , Male , Proteinuria/urine , Sialic Acids/urine , Ticarcillin/urine , Tobramycin/urineABSTRACT
The disposition of coadministered ticarcillin (3 g/1.73 m2) and clavulanic acid (100 mg/1.73 m2) was examined after a 30-min infusion in 24 noninfected subjects with various degrees of renal function. Noncompartmental pharmacokinetic parameters for the individual compounds were determined from plasma concentrations and urinary excretion rates. All clearances (total, renal, and nonrenal) and urinary recoveries of unchanged drug were found to be linearly related to creatinine clearance (CLCR). The steady-state volume of distribution (9.9 and 12.9 liters for ticarcillin and clavulanic acid) approximated the extracellular fluid space and was not related to CLCR. The half-lives increased with reduced renal function and ranged from 56 to 392 min for ticarcillin and 26 to 266 min for clavulanic acid. The clearances of both drugs decreased proportionately with reduction in renal function, facilitating dosing adjustments based on CLCR. Calculations of expected steady-state maximum and minimum concentrations in plasma using constant doses and an extended dosing interval related to CLCR further rationalized use of the 30:1 drug combination ratio for all patients.
Subject(s)
Clavulanic Acids/metabolism , Kidney Diseases/metabolism , Kidney/metabolism , Penicillins/metabolism , Ticarcillin/metabolism , Adolescent , Adult , Clavulanic Acids/pharmacology , Clavulanic Acids/urine , Drug Combinations/metabolism , Drug Combinations/pharmacology , Drug Combinations/urine , Humans , Kidney/drug effects , Kidney/physiopathology , Kidney Diseases/physiopathology , Kinetics , Middle Aged , Ticarcillin/pharmacology , Ticarcillin/urine , beta-Lactamase InhibitorsABSTRACT
High-performance liquid chromatographic assays for the determination of clavulanic acid and ticarcillin in biological fluids are described. The clavulanic acid assay uses serum ultrafiltrate and direct injection of diluted urine with reversed-phase ion-pair/counter-ion chromatography. The ticarcillin assay allows, for the first time, the separation and quantitation of two isomers of ticarcillin. The performance of these assays has been evaluated and found to be satisfactory for routine clinical use and thus the assays have been applied to the study of the pharmacokinetics of these analytes in a subject with renal failure.
Subject(s)
Anti-Bacterial Agents/analysis , Clavulanic Acids/analysis , Penicillins/analysis , Ticarcillin/analysis , Chromatography, High Pressure Liquid , Clavulanic Acid , Clavulanic Acids/blood , Clavulanic Acids/urine , Humans , Isomerism , Kinetics , Ticarcillin/blood , Ticarcillin/urineABSTRACT
Rapid and sensitive high-pressure liquid chromatographic (HPLC) assays for ticarcillin in serum and urine have been developed. Sample pretreatment and optimized chromatographic conditions are presented for a C-18-bonded reversed-phase column used in an internal standard assay method. Ticarcillin has a retention time of or approximately 5.3 min at a flow rate of 1.5 ml/min for a mobile phase of acetonitrile-aqueous 0.06 M sodium biphosphate, pH 2.05, (50.5:100). In a two-step extraction procedure, the ticarcillin extraction efficiencies from serum and urine were 76.1 +/- 4.7 and 80.9 +/- 3.2% respectively. The assay sensitivity limit for ticarcillin in these fluids is approximately 1.0 microgram/ml. A comparison is made of the HPLC and microbiological assay results for ticarcillin in 20 different but equally divided serum samples obtained from two volunteers.
Subject(s)
Penicillins/analysis , Ticarcillin/analysis , Bacteria/drug effects , Chromatography, High Pressure Liquid/methods , Humans , Hydrogen-Ion Concentration , Ticarcillin/blood , Ticarcillin/urineABSTRACT
The excretion of radioactivity has been investigated in 3 healthy volunteers following rapid intravenous administration of 5 g of [35S]-ticarcillin. The radioactive dose was rapidly and completely excreted, since within 4 days 98.5% was recovered, 95% in the urine and 3.5% in faeces. All the urine radioactivity was accounted for as ticarcillin and its penicilloic acid. Plasma and urine samples collected from the volunteers at frequent intervals during the first 6 h of the experiment were assayed for penicillin by an automated chemical method and also for radioactivity. The results obtained by the chemical autoanalyser method were in excellent agreement with the plasma levels of radioactivity. From the data it was possible to calculate the renal clearance of the penicillin, a mean value of 104 ml/min was observed in the 3 volunteers. A further three volunteers were dosed intravenously with a 5 g bolus of non-radiolabelled ticarcillin in a cross-over study with and without predosing with probenecid. Serum samples were analysed by the chemical method for penicillin and the data subjected to pharmacokinetic analysis using a two compartment open model. The results indicate a shift of the distribution equilibrium of ticarcillin from the serum into the peripheral compartment after predosing with probenecid. Furthermore, the mean half-life of ticarcillin in the serum of the three volunteers was significantly increased from 1.3 h to 2.1 h by predosing with probenecid.
Subject(s)
Penicillins/metabolism , Ticarcillin/metabolism , Adult , Humans , Kinetics , Male , Middle Aged , Probenecid/pharmacology , Ticarcillin/blood , Ticarcillin/urineABSTRACT
Piperacillin, ticarcillin, and carbenicillin were administered intravenously to 10 healthy volunteers in a three-way, crossover study. The pharmacokinetics of the three drugs were in general quite similar. The peak serum concentration of piperacillin achieved at the end of a 30-min intravenous infusion was 63.5 +/- 27.6 microgram/ml. During the first 8 h, 67.5% of the dose of piperacillin was excreted in the urine, and the urinary concentration was extremely high. All three penicillins had high volumes of distribution. The serum half-life of the beta elimination phase of carbenicillin was lower than that of either piperacillin or ticarcillin. The volunteers experienced no adverse reactions from the administration of the drugs.
Subject(s)
Carbenicillin/metabolism , Penicillins/metabolism , Ticarcillin/metabolism , Adult , Bacteria/drug effects , Carbenicillin/blood , Carbenicillin/urine , Female , Half-Life , Humans , Kinetics , Male , Metabolic Clearance Rate , Middle Aged , Penicillins/blood , Penicillins/urine , Piperacillin , Pseudomonas aeruginosa/drug effects , Ticarcillin/blood , Ticarcillin/urineABSTRACT
The pharmacokinetics of ticarcillin were determined in patients with abnormal renal function. In individuals with rates of creatinine clearance of greater than 60 ml per min, the half-life (+/- standard deviation) of ticarcillin was 71 +/- 6 min after intravenous administration. In patients with rates of creatinine clearance of 30-60 ml per min, 10-30 ml per min, and less than 10 ml per min, ticarcillin had a half-life of 3.0 +/- 0.6 hr, 8.5 +/- 2.1 hr, and 14.8 +/- 3.7 hr, respectively. Urinary concentrations of ticarcillin after intravenous administration were adequate at all levels of renal function. Ticarcillin was removed by hemodialysis with a reduction in half-life to 3.4 +/- 0.8 hr, but peritoneal dialysis was minimally effective in removing the drug. A program for the use of ticarcillin patients with renal insufficiency was outlined.